A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC (BTC)
A Randomized Phase II Study of Gemcitabine Plus Oxaliplatin (GEMOX) With or Without Cetuximab in Locally Advanced and Metastatic Biliary Tract Cancer (BTC)
Sponsor: Chang Gung Memorial Hospital
This PHASE2 trial investigates Adenocarcinoma of Gallbladder and Cholangiocarcinoma and is currently completed. Chang Gung Memorial Hospital leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
- China Medical University Hospital
- Kaohsiung Medical University
- Kaohsiung Veterans General Hospital.
- Mackay Memorial Hospital
- National Cheng-Kung University Hospital
- National Health Research Institutes, Taiwan
- National Taiwan University Hospital
- Taichung Veterans General Hospital
- Taipei Veterans General Hospital, Taiwan
- Tri-Service General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .